Neural correlates of instrumental responding in the context of alcohol-related cues index disorder severity and relapse risk.


Journal

European archives of psychiatry and clinical neuroscience
ISSN: 1433-8491
Titre abrégé: Eur Arch Psychiatry Clin Neurosci
Pays: Germany
ID NLM: 9103030

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 30 09 2016
accepted: 02 12 2017
pubmed: 10 1 2018
medline: 27 8 2019
entrez: 10 1 2018
Statut: ppublish

Résumé

The influence of Pavlovian conditioned stimuli on ongoing behavior may contribute to explaining how alcohol cues stimulate drug seeking and intake. Using a Pavlovian-instrumental transfer task, we investigated the effects of alcohol-related cues on approach behavior (i.e., instrumental response behavior) and its neural correlates, and related both to the relapse after detoxification in alcohol-dependent patients. Thirty-one recently detoxified alcohol-dependent patients and 24 healthy controls underwent instrumental training, where approach or non-approach towards initially neutral stimuli was reinforced by monetary incentives. Approach behavior was tested during extinction with either alcohol-related or neutral stimuli (as Pavlovian cues) presented in the background during functional magnetic resonance imaging (fMRI). Patients were subsequently followed up for 6 months. We observed that alcohol-related background stimuli inhibited the approach behavior in detoxified alcohol-dependent patients (t = - 3.86, p < .001), but not in healthy controls (t = - 0.92, p = .36). This behavioral inhibition was associated with neural activation in the nucleus accumbens (NAcc) (t

Identifiants

pubmed: 29313106
doi: 10.1007/s00406-017-0860-4
pii: 10.1007/s00406-017-0860-4
doi:

Banques de données

ClinicalTrials.gov
['NCT01679145']

Types de publication

Journal Article

Langues

eng

Pagination

295-308

Références

Nature. 1999 Apr 15;398(6728):567-70
pubmed: 10217139
J Abnorm Psychol. 2001 Feb;110(1):59-66
pubmed: 11261400
Eur Psychiatry. 2002 Jul;17(4):188-93
pubmed: 12231263
Drug Alcohol Depend. 2002 Dec 1;68(3):237-43
pubmed: 12393218
Alcohol Alcohol. 2003 Jan-Feb;38(1):35-9
pubmed: 12554605
Behav Pharmacol. 2003 Mar;14(2):153-60
pubmed: 12658076
Neuron. 2004 May 13;42(3):509-17
pubmed: 15134646
Am J Psychiatry. 2004 Oct;161(10):1783-9
pubmed: 15465974
J Neurosci. 2005 Jan 26;25(4):962-70
pubmed: 15673677
Psychopharmacology (Berl). 2005 Jul;180(2):333-41
pubmed: 15696322
J Stud Alcohol. 2005 Jan;66(1):53-61
pubmed: 15830903
Am J Psychiatry. 2005 Aug;162(8):1515-20
pubmed: 16055774
Nat Neurosci. 2005 Sep;8(9):1234-40
pubmed: 16116445
Nat Neurosci. 2005 Nov;8(11):1481-9
pubmed: 16251991
Addict Biol. 2006 Mar;11(1):2-38
pubmed: 16759333
Eur Addict Res. 2007;13(1):31-8
pubmed: 17172777
Neuroimage. 2007 Apr 1;35(2):787-94
pubmed: 17291784
Alcohol Clin Exp Res. 2007 May;31(5):766-74
pubmed: 17378919
Alcohol Clin Exp Res. 2007 Aug;31(8):1349-57
pubmed: 17550367
J Exp Psychol Anim Behav Process. 2007 Oct;33(4):484-96
pubmed: 17924795
J Neurosci. 2008 Jan 9;28(2):360-8
pubmed: 18184778
J Neurosci. 2008 May 28;28(22):5861-6
pubmed: 18509047
Int J Methods Psychiatr Res. 2008 Jun;17 Suppl 1:S4-S15
pubmed: 18543358
Br J Addict. 1991 Sep;86(9):1119-27
pubmed: 1932883
Pharmacopsychiatry. 2009 May;42 Suppl 1:S56-65
pubmed: 19434556
Biol Psychiatry. 2009 Oct 15;66(8):734-42
pubmed: 19560123
Alcohol Alcohol. 2009 Sep-Oct;44(5):458-63
pubmed: 19734158
Biometrika. 1947;34(1-2):28-35
pubmed: 20287819
Addict Biol. 2011 Jan;16(1):166-75
pubmed: 20331560
Psychopharmacology (Berl). 2010 Jul;211(1):79-86
pubmed: 20431994
Schizophr Bull. 2010 May;36(3):472-85
pubmed: 20453041
J Neurosci. 2010 Jun 2;30(22):7749-53
pubmed: 20519550
Front Integr Neurosci. 2010 Jul 19;4:null
pubmed: 20725634
Psychol Sci. 2011 Apr;22(4):490-7
pubmed: 21389338
Neuron. 2011 Mar 24;69(6):1204-15
pubmed: 21435563
J Exp Psychol Anim Behav Process. 2011 Jul;37(3):261-76
pubmed: 21500933
PLoS Comput Biol. 2011 Apr;7(4):e1002028
pubmed: 21556131
J Neurosci. 2011 Aug 17;31(33):11786-94
pubmed: 21849539
J Neurosci. 2012 Jan 25;32(4):1353-9
pubmed: 22279219
Drug Alcohol Depend. 2013 Jan 1;127(1-3):81-6
pubmed: 22776440
J Exp Psychol Anim Behav Process. 2012 Jul;38(3):266-78
pubmed: 22823420
Arch Gen Psychiatry. 2012 Aug;69(8):842-52
pubmed: 22868938
Nat Neurosci. 2012 Oct;15(10):1356-8
pubmed: 22922785
J Cogn Neurosci. 2013 Sep;25(9):1428-41
pubmed: 23691985
Int J Methods Psychiatr Res. 2013 Jun;22(2):83-99
pubmed: 23788523
Eur J Neurosci. 2013 Dec;38(12):3740-8
pubmed: 24118624
Neuron. 2013 Oct 16;80(2):519-30
pubmed: 24139048
Addict Biol. 2014 May;19(3):402-14
pubmed: 24147643
Prog Brain Res. 2014;211:31-77
pubmed: 24968776
Proc Natl Acad Sci U S A. 2014 Jul 29;111(30):E3149-56
pubmed: 25024177
Neuron. 2014 Sep 3;83(5):1019-39
pubmed: 25189208
Handb Clin Neurol. 2014;125:355-68
pubmed: 25307585
Neuropsychobiology. 2014;70(2):111-21
pubmed: 25359491
Addict Biol. 2016 May;21(3):719-31
pubmed: 25828702
Br J Addict. 1989 Nov;84(11):1353-7
pubmed: 2597811
Psychol Med. 2016 Apr;46(5):1027-35
pubmed: 26841896
Eur J Neurosci. 2016 May;43(9):1229-36
pubmed: 26970240
Drug Alcohol Depend. 2017 Nov 1;180:241-259
pubmed: 28938182
Acta Neurol Scand. 1995 May;91(5):335-45
pubmed: 7639062
Alcohol Clin Exp Res. 1995 Feb;19(1):92-9
pubmed: 7771669
Spat Vis. 1997;10(4):433-6
pubmed: 9176952
Spat Vis. 1997;10(4):437-42
pubmed: 9176953

Auteurs

Daniel J Schad (DJ)

Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Campus Charité Mitte, Berlin, Germany.
Social and Preventive Medicine, Humanwissenschaftliche Fakultät, Area of Excellence Cognitive Sciences, University of Potsdam, Am Neuen Palais 10, 14469, Potsdam, Germany.

Maria Garbusow (M)

Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Campus Charité Mitte, Berlin, Germany.
Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany.

Eva Friedel (E)

Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Campus Charité Mitte, Berlin, Germany.
Berlin Institute of Health (BIH), Berlin, Germany.

Christian Sommer (C)

Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Miriam Sebold (M)

Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Campus Charité Mitte, Berlin, Germany.
Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany.

Claudia Hägele (C)

Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Campus Charité Mitte, Berlin, Germany.

Nadine Bernhardt (N)

Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany.

Stephan Nebe (S)

Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany.

Sören Kuitunen-Paul (S)

Institute of Clinical Psychology and Psychotherapy, Technische Universität Dresden, Dresden, Germany.

Shuyan Liu (S)

Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Campus Charité Mitte, Berlin, Germany.

Uta Eichmann (U)

Department of Psychiatry and Psychotherapy, Vivantes Wenckebach-Klinikum, Berlin, Germany.

Anne Beck (A)

Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Campus Charité Mitte, Berlin, Germany.

Hans-Ulrich Wittchen (HU)

Institute of Clinical Psychology and Psychotherapy, Technische Universität Dresden, Dresden, Germany.
Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-Universität München, Nußbaumstraße 7, 80336, München, Germany.

Henrik Walter (H)

Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Campus Charité Mitte, Berlin, Germany.

Philipp Sterzer (P)

Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Campus Charité Mitte, Berlin, Germany.

Ulrich S Zimmermann (US)

Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Michael N Smolka (MN)

Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany.

Florian Schlagenhauf (F)

Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Campus Charité Mitte, Berlin, Germany.
Max Planck Fellow Group 'Cognitive and Affective Control of Behavioral Adaptation', Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.

Quentin J M Huys (QJM)

Translational Neuromodeling Unit, Department of Biomedical Engineering, ETH Zürich and University of Zürich, Zurich, Switzerland.
Department of Psychiatry, Psychotherapy and Psychosomatics, Hospital of Psychiatry, University of Zurich, Zurich, Switzerland.

Andreas Heinz (A)

Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Campus Charité Mitte, Berlin, Germany.

Michael A Rapp (MA)

Social and Preventive Medicine, Humanwissenschaftliche Fakultät, Area of Excellence Cognitive Sciences, University of Potsdam, Am Neuen Palais 10, 14469, Potsdam, Germany. michael.rapp@uni-potsdam.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH